These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 20146665)
21. Islet-selectivity of G-protein coupled receptor ligands evaluated for PET imaging of pancreatic β-cell mass. Cline GW; Zhao X; Jakowski AB; Soeller WC; Treadway JL Biochem Biophys Res Commun; 2011 Sep; 412(3):413-8. PubMed ID: 21820405 [TBL] [Abstract][Full Text] [Related]
22. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity. Amacher DE Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512 [TBL] [Abstract][Full Text] [Related]
23. Long-term monitoring of transplanted islets using positron emission tomography. Lu Y; Dang H; Middleton B; Campbell-Thompson M; Atkinson MA; Gambhir SS; Tian J; Kaufman DL Mol Ther; 2006 Dec; 14(6):851-6. PubMed ID: 16982215 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of PET Brain Radioligands for Imaging Pancreatic β-Cell Mass: Potential Utility of Bini J; Naganawa M; Nabulsi N; Huang Y; Ropchan J; Lim K; Najafzadeh S; Herold KC; Cline GW; Carson RE J Nucl Med; 2018 Aug; 59(8):1249-1254. PubMed ID: 29371405 [TBL] [Abstract][Full Text] [Related]
25. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus. Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET). Wängler B; Schneider S; Thews O; Schirrmacher E; Comagic S; Feilen P; Schwanstecher C; Schwanstecher M; Shiue CY; Alavi A; Höhnemann S; Piel M; Rösch F; Schirrmacher R Nucl Med Biol; 2004 Jul; 31(5):639-47. PubMed ID: 15219283 [TBL] [Abstract][Full Text] [Related]
28. Toward development of imaging modalities for islets after transplantation: insights from the National Institutes of Health Workshop on Beta Cell Imaging. Paty BW; Bonner-Weir S; Laughlin MR; McEwan AJ; Shapiro AM Transplantation; 2004 Apr; 77(8):1133-7. PubMed ID: 15114073 [TBL] [Abstract][Full Text] [Related]
29. Visualizing pancreatic beta-cell mass with [11C]DTBZ. Simpson NR; Souza F; Witkowski P; Maffei A; Raffo A; Herron A; Kilbourn M; Jurewicz A; Herold K; Liu E; Hardy MA; Van Heertum R; Harris PE Nucl Med Biol; 2006 Oct; 33(7):855-64. PubMed ID: 17045165 [TBL] [Abstract][Full Text] [Related]
30. Potentials of single-cell biology in identification and validation of disease biomarkers. Niu F; Wang DC; Lu J; Wu W; Wang X J Cell Mol Med; 2016 Sep; 20(9):1789-95. PubMed ID: 27113384 [TBL] [Abstract][Full Text] [Related]
31. What are the potential benefits of clinical beta-cell imaging in diabetes mellitus? Göke B Curr Pharm Des; 2010 May; 16(14):1547-9. PubMed ID: 20146664 [TBL] [Abstract][Full Text] [Related]
32. In Vivo Visualization of β-Cells by Targeting of GPR44. Eriksson O; Johnström P; Cselenyi Z; Jahan M; Selvaraju RK; Jensen-Waern M; Takano A; Sörhede Winzell M; Halldin C; Skrtic S; Korsgren O Diabetes; 2018 Feb; 67(2):182-192. PubMed ID: 29208633 [TBL] [Abstract][Full Text] [Related]
33. Efficiency gains in tracer identification for nuclear imaging: can in vivo LC-MS/MS evaluation of small molecules screen for successful PET tracers? Joshi EM; Need A; Schaus J; Chen Z; Benesh D; Mitch C; Morton S; Raub TJ; Phebus L; Barth V ACS Chem Neurosci; 2014 Dec; 5(12):1154-63. PubMed ID: 25247893 [TBL] [Abstract][Full Text] [Related]
34. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus. Kung MP; Hou C; Lieberman BP; Oya S; Ponde DE; Blankemeyer E; Skovronsky D; Kilbourn MR; Kung HF J Nucl Med; 2008 Jul; 49(7):1171-6. PubMed ID: 18552132 [TBL] [Abstract][Full Text] [Related]
35. A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic endocrine cells. Balhuizen A; Massa S; Mathijs I; Turatsinze JV; De Vos J; Demine S; Xavier C; Villate O; Millard I; Egrise D; Capito C; Scharfmann R; In't Veld P; Marchetti P; Muyldermans S; Goldman S; Lahoutte T; Bouwens L; Eizirik DL; Devoogdt N Sci Rep; 2017 Nov; 7(1):15130. PubMed ID: 29123178 [TBL] [Abstract][Full Text] [Related]
36. An outlook on future design of hybrid PET/MRI systems. Zaidi H; Del Guerra A Med Phys; 2011 Oct; 38(10):5667-89. PubMed ID: 21992383 [TBL] [Abstract][Full Text] [Related]
37. Clinical PET imaging of insulinoma and beta-cell hyperplasia. Kauhanen S; Seppänen M; Minn H; Nuutila P Curr Pharm Des; 2010 May; 16(14):1550-60. PubMed ID: 20148760 [TBL] [Abstract][Full Text] [Related]
38. The Current State of Beta-Cell-Mass PET Imaging for Diabetes Research and Therapies. Cheung P; Eriksson O Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944640 [TBL] [Abstract][Full Text] [Related]
39. Noninvasive in vivo measurement of beta-cell mass in mouse model of diabetes. Moore A; Bonner-Weir S; Weissleder R Diabetes; 2001 Oct; 50(10):2231-6. PubMed ID: 11574403 [TBL] [Abstract][Full Text] [Related]